Abstract
Summary
A single injection of 0.5 ml of phenolized tularemia vaccine elicited detectable agglutinating antibodies in 67 of 162(41.4%) patients with hematologic disorders as compared to 45 of 48(93.7%) in normal controls. Particularly significant was the lack of response in 23 of 25 chronic lymphatic leukemia and in 37 of 57 lymphoma patients. In the latter group only 5 of 27 females as compared to 15 of 30 males exhibited antibodies.
Get full access to this article
View all access options for this article.